Trials / Completed
CompletedNCT01564706
A Study of 18F-AV-45 in Healthy Volunteers
Positron Emission Tomography Whole Body Biodistribution Using 18F-AV-45
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
This study will determine how florbetapir F 18 (18F-AV-45) radioactivity is distributed throughout the body.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | florbetapir F 18 | IV injection, 370MBq (10mCi), single dose |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2012-03-28
- Last updated
- 2012-05-18
- Results posted
- 2012-04-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01564706. Inclusion in this directory is not an endorsement.